Company / Capital Returned to Shareholders per Share
Progyny Capital Returned to Shareholders per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.96
FY2025
5-year range
$0.00 / $3.12
FY2021-FY2025
Trend
-69.3%
vs FY2024
Sector context
#62 of 103
Health Care
What the data says
At $0.96, Progyny's capital returned to shareholders per share ranks #62 of 103 in the Health Care sector. Improved from $0.00 to $0.96 over the past 2 years.
Based on SEC 10-K filings.
0.96 in FY2025.
Improved from $0.00 to $0.96 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#62 of 103 in Health CareTop 60% of 103This company $0.96 Sector average $5.07
▼
-81.1% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share decreased 69.3% year-over-year.
- Ranks #62 out of 103 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2024.
- Lowest capital returned to shareholders per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.96 | -69.3% |
| FY2024 | $3.12 | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $0.01 | -95.9% |
| FY2018 | $0.22 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026